Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk - Part 2

EFL020 - Zoledronate to Maintain BMD Gains After Denosumab

Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center, as he talks with Amal Shibli-Rahhal, MD, from University of Iowa

EFL070 – Dosing Strategies for Remission in Graves Disease

For our 70th episode, we review a paper that tries to improve our understanding of remission in Graves’ disease. Long-term thionamide treatm

Common medication for lung cancer symptoms found to limit effectiveness of cancer treatment

LOS ANGELES — Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients

Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy

STUDIO CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Study results from the randomized, prospective phase III ENDURANCE (E1A11) trial, des

EFL057 - Weaning Glucocorticoids and HPA Recovery

Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a study in The Journal of Clinical Endocri

<![CDATA[Relapsed/Refractory Multiple Myeloma: Interpreting MonumenTAL-3 Efficacy and Safety Findings]]>